Singapore markets open in 1 hour 12 minutes
Straits Times Index
3,072.99 -11.71 (-0.38%) S&P 500
4,567.80 +17.22 (+0.38%) Dow
35,950.89 +520.47 (+1.47%) Nasdaq
14,226.22 -32.27 (-0.23%) Bitcoin USD
37,720.13 -147.18 (-0.39%) CMC Crypto 200
781.42 -2.22 (-0.28%)
Aeterna Zentaris Inc. (AEZS)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 03:59PM EST
After hours:
| Previous close | 1.9800 |
| Open | 2.0600 |
| Bid | 1.9300 x 1100 |
| Ask | 2.2200 x 1400 |
| Day's range | 1.9600 - 2.0600 |
| 52-week range | 1.3600 - 4.0000 |
| Volume | |
| Avg. volume | 9,933 |
| Market cap | 9.651M |
| Beta (5Y monthly) | 2.04 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Aeterna Zentaris (AEZS) Reports Q2 Loss, Tops Revenue Estimates
Aeterna Zentaris (AEZS) delivered earnings and revenue surprises of 40.23% and 104.18%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Aeterna (AEZS) Falls 5% on US Sales Halt of Growth Hormone Drug
Aeterna Zentaris (AEZS) announces halting sales of adult growth hormone deficiency diagnosis drug, Macrilen, in the United States in the absence of a commercialization partner. Stock down 5%.
- Zacks
Aeterna Zentaris (AEZS) Reports Q4 Loss, Tops Revenue Estimates
Aeterna Zentaris (AEZS) delivered earnings and revenue surprises of 9.68% and 134.43%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
© 2023 Yahoo. All rights reserved.